RedHill Biopharma reported $22.29M in Current Liabilities for its fiscal quarter ending in June of 2025.





Current Liabilities Change Date
Cara Therapeutics USD 11.04M 362K Sep/2025
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 22.57M 2.29M Dec/2025
Cronos Group USD 48.19M 7.12M Dec/2025
RedHill Biopharma USD 22.29M 64K Jun/2025